Highlights from the Fifth International Meeting on Metabotropic Glutamate Receptors, held September 18-23, 2005, in Taormina, Sicily, Italy. Metabotropic glutamate receptors as therapeutic targets

Drug News Perspect. 2005 Nov;18(9):587-93.

Abstract

The study of metabotropic glutamate receptors (mGluRs) is one of the fastest growing areas of neuropharmacology. The Fifth International Meeting on Metabotropic Glutamate Receptors, held September 18-23, 2005, in Taormina, Sicily, Italy, encompassed more than 80 oral presentations and 70 poster presentations. The role of mGluRs in various physiological and pathological conditions, such as learning and memory, modulation of sensory inputs, control of movement, schizophrenia, anxiety, seizures, addiction to drugs, neurodegeneration and developmental regulation of synaptic circuits, was discussed.

Publication types

  • Congress

MeSH terms

  • Animals
  • Anxiety Disorders / drug therapy
  • Anxiety Disorders / etiology
  • Humans
  • Ligands
  • Neoplasms / drug therapy
  • Neoplasms / etiology
  • Neuroprotective Agents / pharmacology
  • Pain / drug therapy
  • Pain / etiology
  • Parkinson Disease / drug therapy
  • Parkinson Disease / etiology
  • Receptors, Metabotropic Glutamate / drug effects*
  • Receptors, Metabotropic Glutamate / physiology
  • Schizophrenia / drug therapy
  • Schizophrenia / etiology
  • Stress Disorders, Traumatic / drug therapy
  • Stress Disorders, Traumatic / etiology
  • Substance-Related Disorders / drug therapy
  • Substance-Related Disorders / etiology

Substances

  • Ligands
  • Neuroprotective Agents
  • Receptors, Metabotropic Glutamate